Pete Holding
RGN, PgDip, MSc (clinical trials)
Research Nurse / Research Associate
- Median 20-year data collection for the ProtecT trial
- Quantum Biobank: Re-consent of a historical cohort (ProtecT)
My research focusses on the management of prostate cancer.
Prostate cancer is the most common cancer in men - about 40,000 men are diagnosed annually in the UK. The ProtecT (Prostate testing for cancer and Treatment) trial - is a case-finding and randomised controlled trial of treatment effectiveness - the largest of its kind in the UK. I have been involved in this trial since 1999 - from it's initial pilot-phase and then throughout the main trial recruitment and follow up phases.
My current role is to collect the data for the median 20-year analysis. In addition to this, I'm helping to ensure that samples collected from participants recruited onto the ProtecT trial have enduring consent and thus continue to be a resource for basic and translational research. The work ultimately aims to provide future patients diagnosed with prostate cancer the knowledge to determine to best treatment for them.